What drugs does Lonza make?
Lonza operates as a leading global contract development and manufacturing organization that partners with major pharmaceutical companies to produce a wide spectrum of advanced therapeutics. Rather than selling its own proprietary drugs, Lonza manufactures custom clinical and commercial-scale drug substances, complex biologics, monoclonal antibodies, antibody-drug conjugates, cell and gene therapies, and sterile parenteral drug product formats such as vials, pre-filled syringes, and cartridges under rigorous current good manufacturing practices for global healthcare clients.
Related FAQs
Lonza operates its primary United States regional corporate administrative offices and operational headquarters in Morristown, New Jersey.
Lonza Group AG is a leading multinational chemical, pharmaceutical, and biotechnology manufacturing partner headquartered in Basel, Switzerland.
The "Big Four" in global pharmaceuticals refers to the largest multinational drug manufacturing corporations measured by annual revenue, research and development spending, and global market reach.
Workplace reviews for Lonza highlight its strong commitment to professional development, rigorous safety protocols, and competitive compensation packages across its global chemical and biological manufacturing facilities.
Lonza maintains an extensive operational and manufacturing footprint across the United States, supporting pharmaceutical and biotechnology clients with contract development and manufacturing services. Its major U.S.
Loomis payroll schedules and wage disbursement frequencies depend heavily on local labor laws, regional operational guidelines, and specific job classifications across its international cash-handling and secure logistics branches.
Lonza is widely regarded as a supportive and structured workplace that invests heavily in employee training, advanced laboratory technologies, and comprehensive workplace benefits across its international operations.
Lonza provides a comprehensive and competitive benefits framework designed to support the physical, mental, and financial well-being of its employees across its global biotechnology and pharmaceutical operations.
Lonza provides competitive compensation structures for its professional scientists, bioprocess engineers, laboratory technicians, and manufacturing operators across its global facilities.
Executive compensation for Aritz Uribiarte, serving as the President and Chief Executive Officer of Loomis AB (a leading international provider of cash handling, ATM management, and secure logistics solutions headquartered in Sweden), reflects corpor...
Equity research analysts tracking Lonza Group generally maintain a moderate buy consensus rating on the stock, supported by strong fundamentals in contract development and manufacturing for the pharmaceutical and biotech sectors.
For the 2026 fiscal year, Lonza has upgraded its CORE EBITDA margin outlook to a range of 33% to 34%, an increase from its previous guidance of above 32%.
Lonza Group AG, a premier global manufacturing and development partner to the pharmaceutical, biotechnology, and nutrition sectors, has its primary global corporate headquarters located in Basel, Switzerland.
Employees working at Louisiana-Pacific Corporation (LP Building Solutions)—a major manufacturer of sustainable engineered wood building products—receive professional salaries and hourly wages that vary significantly by manufacturing facilities, techn...
The Lonza biomanufacturing facility in Portsmouth, New Hampshire, makes complex therapeutic monoclonal antibodies, recombinant proteins, and advanced viral vector gene therapies using large-scale mammalian cell bioreactor systems.
Lonza stands as a thoroughly legitimate and globally recognized enterprise that serves as a premier development and manufacturing partner for major pharmaceutical and healthcare companies worldwide.
Loomis AB is a major international security and cash-handling services enterprise specializing in secure armored transportation, cash management solutions, and automated teller machine replenishment.
Lonza's large-scale manufacturing facility located in Portsmouth, New Hampshire, operates as a premier contract development and manufacturing organization serving the global biopharmaceutical industry.
Lonza operates as a highly lucrative enterprise, consistently generating substantial operating revenues, positive net income, and robust cash flows from its specialized pharmaceutical contract development and manufacturing operations.
Lonza Group AG reports annual net sales turnover scaling past €6 billion to over €6.5 billion CHF/EUR equivalent.
Lonza Group AG is an authentic, highly respected, and fully legitimate multinational corporation headquartered in Basel, Switzerland, with a history spanning over a century in chemical and biological manufacturing.
Analysts tracking Lonza Group AG project a strong, favorable financial outlook, driven by the company's leading global position as a premier contract development and manufacturing organization (CDMO) for the pharmaceutical and biotech industries.
Store managers, department supervisors, and operational team leads at Stewart's Shops earn comprehensive compensation packages consisting of competitive base salaries, performance-based cash bonuses, and profit-sharing distributions tied directly to ...